206 filings
Page 2 of 11
8-K
1e1phzr1a wdgryy
1 Jul 19
Departure of Directors or Certain Officers
4:33pm
8-K
y86stpivsgs9dj
19 Jun 19
Other Events
5:00pm
8-K
o18 jbh96y0xnail2u
15 Apr 19
W. Mark Watson Elected as Chairman of the Board
5:30pm
8-K
6un0lz zgj2ct8w07b
13 Feb 19
Regulation FD Disclosure
4:31pm
8-K
x564di
31 Dec 18
Entry into a Material Definitive Agreement
5:16pm
8-K
21nhc1qbfv9dhb0 u34v
17 Dec 18
Enter into Updated Collaboration and Funding Agreements
5:15pm
8-K
eun5d03pkgu
5 Nov 18
Regulation FD Disclosure
4:49pm
8-K
1x7gq ea0
10 Jul 18
HedgePath Pharmaceuticals Closes Second Tranche of Mayne Pharma Financing
4:31pm
8-K
cjhjcm8j4progb r4at1
11 Jan 18
HedgePath Pharmaceuticals Secures New Funding from Mayne Pharma to Support BCCNS Clinical and Regulatory Approval Programs
12:00am
8-K
6beoi0hg
20 Dec 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
uur2hjgf fv
5 Oct 17
Other Events
12:00am
8-K
fmvh2
27 Jul 17
HedgePath Pharmaceuticals Receives Clarity From FDA Regarding
12:00am
8-K
6ybwak5e
30 May 17
HedgePath Pharmaceuticals Announces Granting of
12:00am
8-K
nivi6hjki7etk
24 Jan 17
Regulation FD Disclosure
12:00am
8-K
08m7hdj25ggiguvsjb8r
2 Dec 16
Departure of Directors or Certain Officers
12:00am
8-K
j1bzvqp5m6gr iigi9
28 Nov 16
Entry into a Material Definitive Agreement
12:00am
8-K
vrvqq0cnerp oyq9m65
8 Nov 16
Changes in Control of Registrant
12:00am
8-K
x27r7u4f
1 Jun 16
Entry into a Material Definitive Agreement
12:00am
8-K
hct34h
26 May 16
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
e8f9n7yx
3 May 16
Entry into a Material Definitive Agreement
12:00am